Risk Factors for the Development of Stent-Associated Cholangitis Following Endoscopic Biliary Stent Placement

Background and Aim To elucidate the overall risk and risk factors for developing cholangitis following biliary stent placement by endoscopic retrograde cholangiopancreatography (ERCP) and to determine the clinical outcomes of these individuals. Methods We performed a retrospective review of 796 pati...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2019-08, Vol.64 (8), p.2300-2307
Main Authors: Everett, Brendan T., Naud, Shelly, Zubarik, Richard S.
Format: Article
Language:English
Subjects:
Adult
Bile
Bilirubin
Bilirubin - blood
Biochemistry
Biomarkers - blood
Cholangiopancreatography, Endoscopic Retrograde - adverse effects
Cholangiopancreatography, Endoscopic Retrograde - instrumentation
Cholangitis
Cholangitis - diagnosis
Cholangitis - etiology
Cholangitis - mortality
Cholestasis - diagnostic imaging
Cholestasis - etiology
Cholestasis - mortality
Cholestasis - therapy
Comorbidity
Digestive System Neoplasms - complications
Drainage - adverse effects
Drainage - instrumentation
Endoscopy
Female
Gastroenterology
Health aspects
Hepatology
Humans
Male
Medical records
Medicine
Medicine & Public Health
Mortality
Oncology
Original Article
Retrospective Studies
Risk Assessment
Risk Factors
Stent (Surgery)
Stents
Transplant Surgery
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Aim To elucidate the overall risk and risk factors for developing cholangitis following biliary stent placement by endoscopic retrograde cholangiopancreatography (ERCP) and to determine the clinical outcomes of these individuals. Methods We performed a retrospective review of 796 patients who had undergone 1127 ERCPs with biliary stent placement between 2007 and 2015 at a single tertiary care center. There were 91 episodes of stent-associated cholangitis (SAC) during the study period. Data obtained through the medical records included ERCP indication, patient factors (biliary anatomy, demographics, and comorbidities), stent characteristics (material, length, and design), change in serum bilirubin, stent indwelling time, rates and etiologies of bacteremia, and the mortality rate. Results Those with SAC were more likely to have an anatomic biliary stricture (13.1% vs. 2.3%, p  
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-019-05533-6